Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Nichelli

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Neuro-Oncology|August 24, 2022
Proton therapy for adult craniopharyngioma: Experience of a single institution in 91 consecutive patientsArnaud Beddok, Nathaniel Scher, Claire Alapetite, et al.
Neurology|August 8, 2024
Epilepsy in Patients With Primary CNS Lymphoma: Prevalence, Risk Factors, and Prognostic SignificanceOumaima Aboubakr, Caroline Houillier, Agusti Alentorn, et al.
Journal of Neuro-Oncology|June 21, 2022
Chemotherapy is an efficient treatment in primary CNS MALT lymphomaClément Desjardins, Delphine Larrieu-Ciron, Sylvain Choquet, et al.
Neurology|June 3, 2024
Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network StudyDora Herzi, Magali Le Garff-Tavernier, Elise Sourdeau, et al.
The Oncologist|July 28, 2025
Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinibFederico Villanacci, Diego Prost, Francesco Pieri, et al.
Journal of Neuro-Oncology|June 12, 2024
Primary central nervous system lymphomas in immunocompromised patients require specific response criteriaNina Schulz, Lucia Nichelli, Laurence Schenone, et al.
Leukemia & Lymphoma|November 1, 2022
SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination eraAlice Laurenge, Renata Ursu, Emeline Tabouret, et al.
Magnetic Resonance in Medicine|December 11, 2023
Fluid suppression in amide proton transfer-weighted (APTw) CEST imaging: New theoretical insights and clinical benefitsJan-Rüdiger Schüre, Stefano Casagranda, Maria Sedykh, et al.
Journal of Neurosurgery|February 28, 2025
Safety and therapeutic impact of stereotactic biopsy in very elderly patients with brain tumorsLouise Deboeuf, Maximilien Riche, Henri Malaizé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2026
18F-DOPA-PET and advanced MRI improve treatment response assessment in IDH1/2-mutant gliomas treated with IDH inhibitorsDiego Prost, Lucia Nichelli, Laura Rozenblum, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Neuro-Oncology|August 24, 2022
Proton therapy for adult craniopharyngioma: Experience of a single institution in 91 consecutive patientsArnaud Beddok, Nathaniel Scher, Claire Alapetite, et al.
Neurology|August 8, 2024
Epilepsy in Patients With Primary CNS Lymphoma: Prevalence, Risk Factors, and Prognostic SignificanceOumaima Aboubakr, Caroline Houillier, Agusti Alentorn, et al.
Journal of Neuro-Oncology|June 21, 2022
Chemotherapy is an efficient treatment in primary CNS MALT lymphomaClément Desjardins, Delphine Larrieu-Ciron, Sylvain Choquet, et al.
Neurology|June 3, 2024
Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network StudyDora Herzi, Magali Le Garff-Tavernier, Elise Sourdeau, et al.
The Oncologist|July 28, 2025
Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinibFederico Villanacci, Diego Prost, Francesco Pieri, et al.
Journal of Neuro-Oncology|June 12, 2024
Primary central nervous system lymphomas in immunocompromised patients require specific response criteriaNina Schulz, Lucia Nichelli, Laurence Schenone, et al.
Leukemia & Lymphoma|November 1, 2022
SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination eraAlice Laurenge, Renata Ursu, Emeline Tabouret, et al.
Magnetic Resonance in Medicine|December 11, 2023
Fluid suppression in amide proton transfer-weighted (APTw) CEST imaging: New theoretical insights and clinical benefitsJan-Rüdiger Schüre, Stefano Casagranda, Maria Sedykh, et al.
Journal of Neurosurgery|February 28, 2025
Safety and therapeutic impact of stereotactic biopsy in very elderly patients with brain tumorsLouise Deboeuf, Maximilien Riche, Henri Malaizé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2026
18F-DOPA-PET and advanced MRI improve treatment response assessment in IDH1/2-mutant gliomas treated with IDH inhibitorsDiego Prost, Lucia Nichelli, Laura Rozenblum, et al.
Pageof 6